Cell-based Cancer Immunotherapy, Volume 183 provides the latest progress concerning research on anticancer cellular immunotherapies and their immunological, translation, or clinical aspects. Topics covered in this volume include Methods behind clinical DC vaccine products against glioblastoma, Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy, Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients, Identification of TCR repertoire patterns linked with anti-cancer immunotherapy, Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells, Methods behind neoantigen predictions for anticancer vaccines, Methods behind CD137L-DC-EBV-VAX anticancer vaccine, and much more.
Additional sections cover Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies, Methods behind TCR analyses for colorectal cancer-associated TILs, The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays, Humanized mouse models for anti-cancer therapy, In vitro re-challenge of CAR T cells, Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapy, and A murine glioblastoma platform to test cellular therapies with the standard of care.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Methods behind clinical DC vaccine products against glioblastomaR�diger V. Sorg
2. Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy
Jolanda de Vries and Gerty Schreibelt
3. Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients
Stefaan W. Van Gool
4. Identification of TCR repertoire patterns linked with anti-cancer immunotherapy
Kris Laukens and Romi Vandoren
5. Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells
Eva Lion and Kris Laukens
6. Methods behind neoantigen predictions for anticancer vaccines
Cedric Bogaert
7. Methods behind CD137L-DC-EBV-VAX anticancer vaccine
Herbert Schwarz
8. Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies
Dmitri Krysko
9. Methods behind TCR analyses for colorectal cancer-associated TILs
Sara Verbandt, Ting Pu and Sabine Tejpar
10. The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays
Adam Snook
11. Humanized mouse models for anti-cancer therapy
Eleonora Leucci
12. In vitro re-challenge of CAR T cells
Sebastien Walchli and Alicia Villatoro
13. Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapy
Harry D. Bear and Carolyn Haynes
14. A murine glioblastoma platform to test cellular therapies with the standard of care
An Coosemans and Aaron Ziani Zeryouh Jr.
